In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BioControl Medical, Ltd

Latest From BioControl Medical, Ltd

Late-Breaking Trials Picked For Spring ACC meeting

The top trial reports at the American College of Cardiology's signature annual event will address transcatheter aortic valve replacements, atrial fibrillation ablation, heart-failure neurostimulation treatments, and more.

Medical Device Clinical Trials

BioControl Becomes Latest Company To Report Disappointing Outcomes With VNS Therapy For Heart Failure

BioControl Medical has terminated the INOVATE HF trial of its CardioFit vagus nerve stimulator (VNS) for the treatment of heart failure after a pre-specified interim analysis showed the trial had little chance of meeting its primary endpoint. Despite the disappointing results, some physicians remain optimistic about VNS for heart failure and researchers continue to analyze patient subgroups and secondary endpoints to identify potential patients who might benefit from VNS therapy.

Medical Device Clinical Trials

Medtronic Hints At Greater Diagnostic Focus

At the IATI Biomed conference held in Tel Aviv in May, Medtronic executives hint at an increasing focus on diagnostics, personalized medicine, and patient outcomes.

Medical Device Israel

ESC 2014 Shines Spotlight On The Future Of Cardiology

The cardiology sector, long known as one of the most innovative in medtech, has a new wave of technologies on the horizon that could help reinvigorate the sector and create new multibillion-dollar market opportunities for device manufacturers. We take a closer look at these technologies, which include vagal nerve stimulation, remote monitoring for heart failure, as well as innovation in the percutaneous coronary intervention space, all of which were all in the spotlight at the recent European Society of Cardiology Congress 2014 in Barcelona.

Medical Device North America
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices